Tissue | Expression Dynamics | Abbreviation |
Cervix | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Cervix/CLASP1_pca_on_diff_genes.png) | CC: Cervix cancer |
HSIL_HPV: HPV-infected high-grade squamous intraepithelial lesions |
N_HPV: HPV-infected normal cervix |
Endometrium | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Endometrium/CLASP1_pca_on_diff_genes.png) | AEH: Atypical endometrial hyperplasia |
EEC: Endometrioid Cancer |
Esophagus | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Esophagus/CLASP1_pca_on_diff_genes.png) | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias |
LGIN: Low-grade intraepithelial neoplasias |
Lung | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Lung/CLASP1_pca_on_diff_genes.png) | AAH: Atypical adenomatous hyperplasia |
AIS: Adenocarcinoma in situ |
IAC: Invasive lung adenocarcinoma |
MIA: Minimally invasive adenocarcinoma |
Oral Cavity | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/OralCavity/CLASP1_pca_on_diff_genes.png) | EOLP: Erosive Oral lichen planus |
LP: leukoplakia |
NEOLP: Non-erosive oral lichen planus |
OSCC: Oral squamous cell carcinoma |
Prostate | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Prostate/CLASP1_pca_on_diff_genes.png) | BPH: Benign Prostatic Hyperplasia |
Thyroid | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Thyroid/CLASP1_pca_on_diff_genes.png) | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis |
PTC: Papillary thyroid cancer |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003295632 | Lung | MIAC | regulation of actin cytoskeleton organization | 37/967 | 358/18723 | 4.85e-05 | 2.49e-03 | 37 |
GO:190188831 | Lung | MIAC | regulation of cell junction assembly | 25/967 | 204/18723 | 5.46e-05 | 2.75e-03 | 25 |
GO:001063922 | Lung | MIAC | negative regulation of organelle organization | 36/967 | 348/18723 | 5.99e-05 | 2.98e-03 | 36 |
GO:004206023 | Lung | MIAC | wound healing | 41/967 | 422/18723 | 7.92e-05 | 3.66e-03 | 41 |
GO:004477221 | Lung | MIAC | mitotic cell cycle phase transition | 41/967 | 424/18723 | 8.79e-05 | 3.92e-03 | 41 |
GO:003227323 | Lung | MIAC | positive regulation of protein polymerization | 19/967 | 138/18723 | 8.89e-05 | 3.93e-03 | 19 |
GO:003223132 | Lung | MIAC | regulation of actin filament bundle assembly | 16/967 | 105/18723 | 9.36e-05 | 4.10e-03 | 16 |
GO:005149431 | Lung | MIAC | negative regulation of cytoskeleton organization | 21/967 | 163/18723 | 1.03e-04 | 4.44e-03 | 21 |
GO:011002032 | Lung | MIAC | regulation of actomyosin structure organization | 15/967 | 100/18723 | 1.84e-04 | 6.73e-03 | 15 |
GO:00070515 | Lung | MIAC | spindle organization | 22/967 | 184/18723 | 2.14e-04 | 7.50e-03 | 22 |
GO:00311162 | Lung | MIAC | positive regulation of microtubule polymerization | 8/967 | 33/18723 | 2.15e-04 | 7.50e-03 | 8 |
GO:005149222 | Lung | MIAC | regulation of stress fiber assembly | 14/967 | 91/18723 | 2.27e-04 | 7.78e-03 | 14 |
GO:00443192 | Lung | MIAC | wound healing, spreading of cells | 8/967 | 34/18723 | 2.69e-04 | 8.61e-03 | 8 |
GO:00905052 | Lung | MIAC | epiboly involved in wound healing | 8/967 | 34/18723 | 2.69e-04 | 8.61e-03 | 8 |
GO:00467851 | Lung | MIAC | microtubule polymerization | 13/967 | 83/18723 | 3.15e-04 | 9.67e-03 | 13 |
GO:00905042 | Lung | MIAC | epiboly | 8/967 | 35/18723 | 3.33e-04 | 1.01e-02 | 8 |
GO:003003832 | Lung | MIAC | contractile actin filament bundle assembly | 15/967 | 106/18723 | 3.52e-04 | 1.04e-02 | 15 |
GO:004314932 | Lung | MIAC | stress fiber assembly | 15/967 | 106/18723 | 3.52e-04 | 1.04e-02 | 15 |
GO:00311122 | Lung | MIAC | positive regulation of microtubule polymerization or depolymerization | 8/967 | 37/18723 | 4.98e-04 | 1.33e-02 | 8 |
GO:0002011 | Lung | MIAC | morphogenesis of an epithelial sheet | 10/967 | 57/18723 | 6.08e-04 | 1.50e-02 | 10 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CLASP1 | SNV | Missense_Mutation | | c.2725N>T | p.His909Tyr | p.H909Y | Q7Z460 | protein_coding | deleterious(0) | possibly_damaging(0.789) | TCGA-A2-A0EV-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CLASP1 | SNV | Missense_Mutation | rs748266679 | c.3997C>T | p.Arg1333Trp | p.R1333W | Q7Z460 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-A8-A08J-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
CLASP1 | SNV | Missense_Mutation | | c.704N>G | p.Ser235Cys | p.S235C | Q7Z460 | protein_coding | deleterious(0) | possibly_damaging(0.471) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
CLASP1 | SNV | Missense_Mutation | novel | c.1078N>T | p.Asp360Tyr | p.D360Y | Q7Z460 | protein_coding | deleterious(0) | possibly_damaging(0.789) | TCGA-AC-A3QQ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CLASP1 | SNV | Missense_Mutation | novel | c.1078G>A | p.Asp360Asn | p.D360N | Q7Z460 | protein_coding | deleterious(0) | benign(0.36) | TCGA-AR-A0U2-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Hormone Therapy | tamoxiphen | PD |
CLASP1 | SNV | Missense_Mutation | rs751028676 | c.3559N>A | p.Glu1187Lys | p.E1187K | Q7Z460 | protein_coding | deleterious(0.03) | probably_damaging(0.991) | TCGA-B6-A1KN-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
CLASP1 | SNV | Missense_Mutation | | c.2719N>A | p.Asp907Asn | p.D907N | Q7Z460 | protein_coding | deleterious(0) | possibly_damaging(0.887) | TCGA-BH-A0HF-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD |
CLASP1 | SNV | Missense_Mutation | | c.71G>A | p.Gly24Asp | p.G24D | Q7Z460 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-BH-A18G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CLASP1 | SNV | Missense_Mutation | | c.1382N>C | p.Arg461Thr | p.R461T | Q7Z460 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-C8-A1HM-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | doxorubicin | CR |
CLASP1 | SNV | Missense_Mutation | novel | c.2790T>G | p.Asp930Glu | p.D930E | Q7Z460 | protein_coding | tolerated(0.6) | benign(0.031) | TCGA-LL-A441-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | CR |